Xarelto was a joint development by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson and Bayer Health Care. Considered to be one of the new generation of blood thinners (along with Pradaxa), Xarelto has been approved to treat a limited variety of conditions.
Millions of Americans have been prescribed Xarelto, an anticoagulant to reduce the risk of:
- Reduce the risk of irregular heartbeat (atrial fibrillation)
- Reduce the risk of blood clots
- Pulmonary embolism
- Deep vein thrombosis
- Blood thinners all carry some risk of internal bleeding, however, Blood Thinner Medication Xarelto has been linked to an extensive increased risk of internal bleeding to patients prescribed the drug and the manufacturer has failed to provide adequate warnings to physicians in the medical community and consumers.
In addition it is an option for reducing the risk of blood clots in patients who have just had knee or hip replacement surgery. People with an irregular heartbeat are at greater risk of stroke and should not stop taking Xarelto without talking to the prescribing physician. Patients taking the drug who receive spinal anesthesia should be closely monitored for symptoms of spinal or epidural blood clots.
Symptoms and Side Effects
Xarelto is an anticoagulant that can have dangerous side effects including uncontrollable bleeding. It is similar to the drug Pradaxa, which has also come under recent scrutiny for excessive bleeding events. Signs and symptoms that require medical attention include:
- Unexpected or Unusual Bleeding
- Severe Bleeding You Can’t Control
- Red, Pink or Brown Urine
- Vomit Blood or Vomit that Looks Like Coffee Grounds
- Bright Red or Tar-like Black Stools
- Headaches, Dizziness or Muscle Weakness
- Internal Bleeding
- Gastrointestinal Bleeding
- Kidney Bleeding
- Brain Hemorrhaging
- Death resulting from bleeding out
The new generation of drugs that were marketed to reduce the number of symptoms and side effects are now considered to have just as high a risk for bleeding as the drugs they replaced, with one important difference. Neither Xarelto nor Pradaxa have an antidote or reversal agent that can be administered to stop uncontrollable bleeding.
The manufacturer (Bayer) and (Jannsen Pharmaceuticals) may have opened the door to future litigations by attempting to increase their profits by getting Xarelto approved for new uses (which were recently denied by the FDA). In addition, there is a growing debate in regards to the failure to provide adequate warnings about a sudden discontinuation of use. If you or someone you love was hospitalized with severe bleeding or experienced an adverse effect (or succumbed) following discontinuation of the drug, you should seek immediate legal counsel. Contact us at (956) 688-7400 or toll free at (866) 668-7302 to learn more about a Xarelto lawsuit.